Td Private Client Wealth LLC Biogen Inc. Transaction History
Td Private Client Wealth LLC
- $3.48 Trillion
- Q3 2024
A detailed history of Td Private Client Wealth LLC transactions in Biogen Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 385 shares of BIIB stock, worth $60,833. This represents 0.0% of its overall portfolio holdings.
Number of Shares
385
Previous 308
25.0%
Holding current value
$60,833
Previous $71.4 Million
4.52%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding BIIB
# of Institutions
1,036Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.64 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.58 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.3 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.16 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$811 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $22.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...